Orgenesis Inc. Net Debt/EBITDA

Net Debt/EBITDA of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt/EBITDA growth rates and interactive chart.


Highlights and Quick Summary

  • Net Debt/EBITDA for the quarter ending March 31, 2022 was -3.71 (a 304.72% increase compared to previous quarter)
  • Year-over-year quarterly Net Debt/EBITDA decreased by -142.57%
  • Annual Net Debt/EBITDA for 2021 was -0.39 (a -213.43% decrease from previous year)
  • Annual Net Debt/EBITDA for 2020 was 0.35 (a -147.75% decrease from previous year)
  • Annual Net Debt/EBITDA for 2019 was -0.73 (a -181.01% decrease from previous year)
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt/EBITDA of Orgenesis Inc.

Most recent Net Debt/EBITDAof ORGS including historical data for past 10 years.

Interactive Chart of Net Debt/EBITDA of Orgenesis Inc.

Orgenesis Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -3.71
2021 -0.92 0.35 8.72 -57.88 -0.39
2020 0.65 8.62 3.29 15.46 0.35
2019 -3.02 -0.21 1.36 1.4 -0.73
2018 0.0 150.44 0.91 -0.12 0.9
2017 -2.66 -4.12 0.0 0.0 -0.56
2016 0.0 -2.36 0.0 0.0 0.0 0.0 -1.07
2015 0.0 -1.18
2014 0.0 -0.26
2013 0.0 -0.05
2012 0.0 0.0
2011 0.0

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology